•
Dec 31, 2022

AN2 Therapeutics Q4 2022 Earnings Report

EPS
-$0.61
Previous year: $2.54
-124.0%
Cash and Equivalents
$27.2M
Previous year: $12.1M
+125.0%
Total Assets
$103M
Previous year: $65.3M
+57.0%

AN2 Therapeutics

AN2 Therapeutics